# Polycystic Ovary Syndrome - Improving Outcomes

> **NCT01504321** · PHASE4 · COMPLETED · sponsor: **Baker Heart and Diabetes Institute** · enrollment: 42 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Moxonidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01504321
- **Lead sponsor:** Baker Heart and Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-05
- **Final completion:** 2015-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01504321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01504321, "Polycystic Ovary Syndrome - Improving Outcomes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01504321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*